Today, the U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the ...

The committee concluded that current evidence did not support the recommended doses of the ingredient in OTC products for a variety of drugs, including cold, cough, allergy, bronchodilator, and ...